Belmont, CA, United States of America

Jorge DiMartino

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Jorge DiMartino

Introduction

Jorge DiMartino is a notable inventor based in Belmont, CA (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of 5 patents, his work focuses on combination therapies for malignancies.

Latest Patents

DiMartino's latest patents include methods and compositions for treating cancers in patients carrying an IDH2 mutation. This involves using a combination of an inhibitor of a mutant IDH2 enzyme and a DNA demethylating agent. Another significant patent addresses hematological malignancies in patients with an IDH1 mutation. This patent utilizes a specific compound along with a DNA demethylating agent to enhance treatment efficacy.

Career Highlights

Throughout his career, Jorge DiMartino has worked with prominent companies such as Celgene Corporation and Agios Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative therapies.

Collaborations

DiMartino has collaborated with talented individuals in the field, including Kyle MacBeth and Aaron Nguyen. These partnerships have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

Jorge DiMartino's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to improving patient outcomes through advanced therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…